A study in humans identified the mir-4473 as differentially expressed in patients with recurrent myocardial infarction after percutaneous coronary intervention, where it was downregulated in whole blood and upregulated in plasma, with these changes being significant in both sample types [Onuoha et al. DOI:10.1111/cts.13307].